» Articles » PMID: 15583011

Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory

Overview
Journal J Exp Med
Date 2004 Dec 8
PMID 15583011
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidation of low density lipoprotein (LDL) generates a variety of oxidatively modified lipids and lipid-protein adducts that are immunogenic and proinflammatory, which in turn contribute to atherogenesis. Cells undergoing apoptosis also display oxidized moieties on their surface membranes, as determined by binding of oxidation-specific monoclonal antibodies. In the present paper, we demonstrated by mass spectrometry that in comparison with viable cells, membranes of cells undergoing apoptosis contain increased levels of biologically active oxidized phospholipids (OxPLs). Indeed, immunization of mice with syngeneic apoptotic cells induced high autoantibody titers to various oxidation-specific epitopes of oxidized LDL, including OxPLs containing phosphorylcholine, whereas immunization with viable thymocytes, primary necrotic thymocytes, or phosphate-buffered saline did not. Reciprocally, these antisera specifically bound to apoptotic cells through the recognition of oxidation-specific epitopes. Moreover, splenocyte cultures from mice immunized with apoptotic cells spontaneously released significant levels of T helper cell (Th) 1 and Th2 cytokines, whereas splenocytes from controls yielded only low levels. Finally, we demonstrated that the OxPLs of apoptotic cells activated endothelial cells to induce monocyte adhesion, a proinflammatory response that was abrogated by an antibody specific to oxidized phosphatidylcholine. These results suggest that apoptotic cell death generates oxidatively modified moieties, which can induce autoimmune responses and a local inflammatory response by recruiting monocytes via monocyte-endothelial cell interaction.

Citing Articles

The complement system in lipid-mediated pathologies.

Alic L, Dendinovic K, Papac-Milicevic N Front Immunol. 2024; 15:1511886.

PMID: 39635529 PMC: 11614835. DOI: 10.3389/fimmu.2024.1511886.


Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.

Ondracek A, Afonyushkin T, Aszlan A, Taqi S, Koller T, Artner T Eur Heart J. 2024; 46(10):926-939.

PMID: 39215577 PMC: 11887544. DOI: 10.1093/eurheartj/ehae584.


Atherosclerosis antigens as targets for immunotherapy.

Raposo-Gutierrez I, Rodriguez-Ronchel A, Ramiro A Nat Cardiovasc Res. 2024; 2(12):1129-1147.

PMID: 39196152 DOI: 10.1038/s44161-023-00376-x.


Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.

Ransegnola B, Pattarabanjird T, McNamara C Arterioscler Thromb Vasc Biol. 2024; 44(9):1906-1915.

PMID: 39022832 PMC: 11338718. DOI: 10.1161/ATVBAHA.124.319847.


Temperature sensitivity of bat antibodies links metabolic state of bats with antigen-recognition diversity.

Toshkova N, Zhelyzkova V, Reyes-Ruiz A, Haerens E, Deus M, Lacombe R Nat Commun. 2024; 15(1):5878.

PMID: 38997292 PMC: 11245544. DOI: 10.1038/s41467-024-50316-x.


References
1.
Green D, Beere H . Apoptosis. Gone but not forgotten. Nature. 2000; 405(6782):28-9. DOI: 10.1038/35011175. View

2.
Shaw P, Horkko S, Chang M, Curtiss L, Palinski W, Silverman G . Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 2000; 105(12):1731-40. PMC: 378505. DOI: 10.1172/JCI8472. View

3.
Luscinskas F, Gerszten R, Garcia-Zepeda E, Lim Y, Yoshida M, Ding H . C-C and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Ann N Y Acad Sci. 2000; 902:288-93. DOI: 10.1111/j.1749-6632.2000.tb06324.x. View

4.
Marathe G, Harrison K, Murphy R, Prescott S, Zimmerman G, McIntyre T . Bioactive phospholipid oxidation products. Free Radic Biol Med. 2000; 28(12):1762-70. DOI: 10.1016/s0891-5849(00)00234-3. View

5.
Fadok V, Bratton D, Henson P . Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest. 2001; 108(7):957-62. PMC: 200959. DOI: 10.1172/JCI14122. View